Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep;8(5):1806–1816. doi: 10.21037/tcr.2019.08.31

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2019 Translational Cancer Research. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

PMC Copyright notice

Correlation of ITGA7 and CD44 with DFS and OS in NSCLC patients. Comparison of DFS (A) and OS (B) between ITGA7 high expression and CD44 high expression group, ITGA7 high expression and CD44 low expression group, ITGA7 low expression and CD44 high expression group as well as ITGA7 low expression and CD44 low expression group. Comparison of DFS (C) and OS (D) between ITGA7 high expression and CD44 high expression group with other patients. The survivals for NSCLC patients were exhibited by Kaplan-Meier curve and the comparison of survival between groups were performed by log-rank test. The factors effecting DFS and OS were examined by univariate and multivariate Cox’s proportional hazards regression model analyses. P<0.05 was considered significant. DFS, disease-free survival; OS, overall survival; ITGA7, integrin-α7; HR, hazard ratio; NSCLC, non-small cell lung cancer.